QQQ   439.00 (+0.86%)
AAPL   180.75 (-0.37%)
MSFT   413.64 (+1.45%)
META   490.13 (+1.26%)
GOOGL   138.46 (+1.53%)
AMZN   176.76 (+2.08%)
TSLA   201.88 (-0.08%)
NVDA   791.12 (+1.87%)
NIO   5.74 (+5.71%)
AMD   192.53 (+9.06%)
BABA   74.02 (-0.76%)
T   16.93 (-0.18%)
F   12.43 (+1.06%)
MU   90.61 (+1.00%)
CGC   3.29 (-2.08%)
GE   156.83 (+0.78%)
DIS   111.51 (+0.64%)
AMC   4.34 (-13.21%)
PFE   26.55 (-1.81%)
PYPL   60.34 (+0.15%)
XOM   104.52 (+0.19%)
QQQ   439.00 (+0.86%)
AAPL   180.75 (-0.37%)
MSFT   413.64 (+1.45%)
META   490.13 (+1.26%)
GOOGL   138.46 (+1.53%)
AMZN   176.76 (+2.08%)
TSLA   201.88 (-0.08%)
NVDA   791.12 (+1.87%)
NIO   5.74 (+5.71%)
AMD   192.53 (+9.06%)
BABA   74.02 (-0.76%)
T   16.93 (-0.18%)
F   12.43 (+1.06%)
MU   90.61 (+1.00%)
CGC   3.29 (-2.08%)
GE   156.83 (+0.78%)
DIS   111.51 (+0.64%)
AMC   4.34 (-13.21%)
PFE   26.55 (-1.81%)
PYPL   60.34 (+0.15%)
XOM   104.52 (+0.19%)
QQQ   439.00 (+0.86%)
AAPL   180.75 (-0.37%)
MSFT   413.64 (+1.45%)
META   490.13 (+1.26%)
GOOGL   138.46 (+1.53%)
AMZN   176.76 (+2.08%)
TSLA   201.88 (-0.08%)
NVDA   791.12 (+1.87%)
NIO   5.74 (+5.71%)
AMD   192.53 (+9.06%)
BABA   74.02 (-0.76%)
T   16.93 (-0.18%)
F   12.43 (+1.06%)
MU   90.61 (+1.00%)
CGC   3.29 (-2.08%)
GE   156.83 (+0.78%)
DIS   111.51 (+0.64%)
AMC   4.34 (-13.21%)
PFE   26.55 (-1.81%)
PYPL   60.34 (+0.15%)
XOM   104.52 (+0.19%)
QQQ   439.00 (+0.86%)
AAPL   180.75 (-0.37%)
MSFT   413.64 (+1.45%)
META   490.13 (+1.26%)
GOOGL   138.46 (+1.53%)
AMZN   176.76 (+2.08%)
TSLA   201.88 (-0.08%)
NVDA   791.12 (+1.87%)
NIO   5.74 (+5.71%)
AMD   192.53 (+9.06%)
BABA   74.02 (-0.76%)
T   16.93 (-0.18%)
F   12.43 (+1.06%)
MU   90.61 (+1.00%)
CGC   3.29 (-2.08%)
GE   156.83 (+0.78%)
DIS   111.51 (+0.64%)
AMC   4.34 (-13.21%)
PFE   26.55 (-1.81%)
PYPL   60.34 (+0.15%)
XOM   104.52 (+0.19%)
NASDAQ:MRAI

Marpai (MRAI) Stock Price, News & Analysis

$1.42
-0.06 (-4.05%)
(As of 02/29/2024 ET)
Today's Range
$1.40
$1.57
50-Day Range
$0.85
$1.85
52-Week Range
$0.33
$13.60
Volume
121,514 shs
Average Volume
803,163 shs
Market Capitalization
$11.09 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

Marpai MarketRank™ Stock Analysis

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Healthy
1.86% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
1.43mentions of Marpai in the last 14 days
Based on 2 Articles This Week
Insider Trading
Acquiring Shares
$1.42 M Bought Last Quarter
Proj. Earnings Growth
N/A

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.48 out of 5 stars

Business Services Sector

242nd out of 319 stocks

Miscellaneous Health & Allied Services, Not Elsewhere Classified Industry

6th out of 6 stocks


MRAI stock logo

About Marpai Stock (NASDAQ:MRAI)

Marpai, Inc., a technology-driven healthcare payer, focuses on providing services to the self-insured employer market in the United States and Israel. The company offers ancillary services, such as care management, case management, actuarial services, health savings account administration, bill review and cost containment services. It also develops artificial intelligence and healthcare technology. Marpai, Inc. was incorporated in 2021 and is headquartered in New York, New York.

MRAI Stock Price History

MRAI Stock News Headlines

Marpai Adjusts AXA Deal Terms, Sells Future Receipts
MARPAI ANNOUNCES KEY FINANCIAL AGREEMENTS
This is the #1 Stock to Buy for the AI Tidal Wave
Marc Chaikin warned people about NVDA before its 2023 bull run - now he’s naming his next pick or the AI tidal wave. Learn more here.
Marpai CEO & Director Acquires 84% More Stock
Why Is Marpai (MRAI) Stock Up 27% Today?
Marpai appoints John Powers as its CEO
MARPAI HIRES JOHN POWERS AS PRESIDENT
Critical asset just had biggest fall on record
What many consider America's critical financial asset suffers biggest fall on record. Expert says: "it's very bad for millions, protect yourself now."
Marpai Inc Class A
CEO & Director of Marpai Picks Up 29% More Stock
MARPAI TO HOST INVESTOR WEBCAST ON NOVEMBER 29, 2023
Marpai Inc - Ordinary Shares Class A
MARPAI, INC. REPORTS THIRD QUARTER 2023 RESULTS
Dow Gains Over 100 Points; Wynn Resorts Earnings Top Views
Why Is Marpai (MRAI) Stock Up 100% Today?
Marpai CEO Edmundo Gonzalez, CFO Yoram Bibring Step Down
Marpai Inc Class A MRAI
CEO Edmundo Gonzalez Buys 42,000 Shares of Marpai Inc (MRAI)
See More Headlines
Receive MRAI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Marpai and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
2/29/2024
Next Earnings (Estimated)
4/03/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Miscellaneous health & allied services, not elsewhere classified
Sub-Industry
N/A
Current Symbol
NASDAQ:MRAI
Fax
N/A
Employees
303
Year Founded
N/A

Profitability

Net Income
$-26,470,000.00
Pretax Margin
-90.86%

Debt

Sales & Book Value

Annual Sales
$36.08 million
Book Value
$1.15 per share

Miscellaneous

Free Float
4,757,000
Market Cap
$11.09 million
Optionable
No Data
Beta
5.31
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Key Executives

  • Mr. Yaron I. Eitan (Age 68)
    Co-Founder & Chairman of the Board
  • Mr. Damien Francis Lamendola (Age 68)
    CEO & Director
  • Mr. John Powers
    President
  • Dr. Eli David (Age 42)
    Co-Founder & Chief Science Advisor
  • Mr. Steve Johnson (Age 54)
    CFO & Company Secretary
  • Mr. Gonen Antebi (Age 52)
    Chief Operating Officer
  • Ms. Pamela Burns
    Vice President of Enterprise Sales
  • Simon Li
    Vice President














MRAI Stock Analysis - Frequently Asked Questions

Should I buy or sell Marpai stock right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Marpai in the last year. There are currently 1 hold rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" MRAI shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in MRAI, but not buy additional shares or sell existing shares.
View MRAI analyst ratings
or view top-rated stocks.

How have MRAI shares performed in 2024?

Marpai's stock was trading at $1.75 on January 1st, 2024. Since then, MRAI shares have decreased by 18.9% and is now trading at $1.42.
View the best growth stocks for 2024 here
.

Are investors shorting Marpai?

Marpai saw a decline in short interest during the month of February. As of February 15th, there was short interest totaling 57,900 shares, a decline of 62.7% from the January 31st total of 155,100 shares. Based on an average daily trading volume, of 1,430,000 shares, the short-interest ratio is presently 0.0 days. Approximately 1.9% of the shares of the stock are short sold.
View Marpai's Short Interest
.

When is Marpai's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, April 3rd 2024.
View our MRAI earnings forecast
.

When did Marpai's stock split?

Marpai shares reverse split on Thursday, June 29th 2023. The 1-4 reverse split was announced on Thursday, June 29th 2023. The number of shares owned by shareholders was adjusted after the market closes on Thursday, June 29th 2023. An investor that had 100 shares of stock prior to the reverse split would have 25 shares after the split.

When did Marpai IPO?

(MRAI) raised $25 million in an initial public offering (IPO) on Wednesday, October 27th 2021. The company issued 6,300,000 shares at $4.00 per share. ThinkEquity acted as the underwriter for the IPO.

Who are Marpai's major shareholders?

Marpai's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (1.24%). Insiders that own company stock include Damien Lamendola, Edmundo Gonzalez, Jane Cavalier, Robert M Pons, Ronnie Brown, Vincent Kane, Yaron Eitan and Yoram Bibring.
View institutional ownership trends
.

How do I buy shares of Marpai?

Shares of MRAI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:MRAI) was last updated on 2/29/2024 by MarketBeat.com Staff